Evidence map›Paper›PMID 42156951›Full record

ArticleScientific reports2026

Characterization and evaluation of the efficacy of phage E21 therapy in a wound animal model of biofilm-associated Pseudomonas aeruginosa infection.

Ahmed M Salah Eldin, Ahmed S Abu Zaid, Rania Ibrahim Shebl, Mahmoud A Yassien

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ahmed M Salah EldinDepartment of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th October, Giza, Egypt.ORCID 0009-0003-9933-7518
Ahmed S Abu ZaidDepartment of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity St. Abbassia, POB: 11566, Cairo, Egypt.ORCID 0009-0008-2335-9733
Rania Ibrahim SheblDepartment of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th October, Giza, Egypt.ORCID 0000-0003-2877-6196
Mahmoud A YassienDepartment of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Organization of African Unity St. Abbassia, POB: 11566, Cairo, Egypt. mahmoud.yassien@pharma.asu.edu.eg.ORCID 0009-0008-8645-9280

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin infections caused by strong biofilm Pseudomonas aeruginosa (P. aeruginosa) are considered a serious public health issue because of the increased resistance toward the currently available antibiotics. Consequently, innovative therapeutic strategies have emerged to address these challenging infections. Among them, phage therapy stands out, in which highly potent lytic bacteriophages (phages) are specifically selected to target and eradicate the responsible pathogens. In this study, Pseudomonas phage E21 was recovered from sewage, and it genetically belongs to the Lavrentievirus genus, Casjensviridae family. The genetic characterization of the isolated phage reveals the presence of highly potent lytic enzymes, which play a critical role in effectively suppressing the growth of the targeted pathogens. The phage has high stability patterns over a wide range of temperatures and pH values (65 ℃ and 3-11). Carboxymethylcellulose was used to formulate a hydrogel for the evaluation of the bacteriophage's efficacy against biofilm-associated wound infection in a suitable animal model. The result of the preclinical study confirmed the efficacy of isolated phage in the therapy of biofilm-associated wound infection.

Indexed as

BiofilmsPhage TherapyPseudomonas aeruginosaPseudomonas InfectionsPseudomonas PhagesWound InfectionAnimalsDisease Models, AnimalCarboxy methylcellulosePhage therapyPseudomonas aeruginosaSkin infectionStrong biofilm

Identifiers

PMID42156951
PMCPMC13186941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.